H. Yokoyama et al., LOSARTAN AND CAPTOPRIL FOLLOW DIFFERENT MECHANISMS TO DECREASE PRESSOR-RESPONSES IN THE PITHED RAT, Clinical and experimental pharmacology and physiology, 24(9-10), 1997, pp. 697-705
1. We investigated the effects of losartan and captopril on noradrenal
ine (NA) release and vascular reactivity to NA in the pithed rat, 2, T
he presser responses to sympathetic nerve stimulation (SNS) before and
after i,v, administration of captopril (1 mg/kg), losartan (1 and 10
mg/kg), sodium nitroprusside (SNP; 5 mu g/kg per min), losartan (1mg/k
g) + captopril (1mg/kg), captopril (1mg/kg) + losartan (1mg/kg) or the
bradykinin B-2 receptor antagonist HOE140 (1mg/kg) + captopril (1mg/k
g) were measured, Plasma NA concentrations were measured during 60 s S
NS before and after losartan (1mg/kg), captopril (1mg/kg), SNP (5 mu g
/kg per min) or HOE140 (1mg/kg) + captopril (1mg/kg), Presser response
s to exogenous NA were measured before and after administration of los
artan (1 mg/kg), captopril (1 mg/kg), HOE 140 (1 mg/kg) + captopril (1
mg/kg) or the nitric oxide synthase (NO) inhibitor, NG-nitro-L-arginin
e methyl ester (L-NAME; 10 mg/kg) + captopril (1 mg/kg). 3, Captopril,
losartan and SNP decreased frequency-response curves to a similar ext
ent, The captopril-induced decrease in presser responses to SNS was re
stored by pretreatment with HOE 140, Adding captopril to losartan decr
eased the curve more than did adding losartan to captopril, Both losar
tan, captopril and HOE 140 + captopril significantly decreased the pla
sma NA concentration after SNS (34.1+/-5.0, 27.4+/-2.6 and 41.4+/-8.1%
, respectively), Sodium nitroprusside did not change the plasma NA con
centration after SNS (3.8+/-28.2%), The dose-response curves to i,v, N
A were not affected by losartan, but were significantly decreased by c
aptopril, However, responses to NA that were reduced by captopril were
restored to control values by pretreatment with HOE 140 or L-NAME.4,
We suggest that both losartan and captopril decrease presser responses
to SNS by inhibiting NA release from sympathetic nerve endings; howev
er, captopril also decreases 'vascular reactivity' to NA, which is med
iated by nitric oxide produced by activation of the bradykinin B-2 rec
eptors.